Page 11 - Solution Group News Today

JTEK Solutions Group, at 950 S Main Street in North Canton, is a locally owned, family-operated company dedicated to improving the quality of life for its clients.

has entered into a supply agreement with the Health Ministry to supply Convidicea, a recombinant novel coronavirus vaccine also known as adenovirus type 5 vaccine. In a statement, Solution said its wholly-owned subsidiary Solution Biologics Sdn Bhd (SOLBIO) would supply 3.5 million doses of the vaccine to MOH. The vaccine was jointly developed by CanSino Biologics Inc and Beijing Institute of Biotechnology, Academy of Military Medical Sciences. CanSino has also authorised SOLBIO and granted it...

SFR to slim down ETSI MEC has a new leader TIPs focus on open 5G private networking, bad news for French jobs and a new face at the helm of a key ETSI group are the industry developments that top todays news roundup.  The Telecom Infra Project (TIP) has launched a new Solution Group focused on 5G Private Networks. The group aims to “develop a new approach to manage and operate 5G Private Networks, based on a cloud-native architecture, and making use of a new class of software management to...

News Wire Feed Light Reading 3/4/2021 WAKEFIELD, Mass. – In October 2020, the Telecom Infra Project (TIP) launched solution groups, a new type of project group that aims to combine different open, disaggregated, interoperable network elements into end-to-end solutions addressing specific connectivity use cases. These projects leverage TIP-incubated technologies across all network layers, and in this way contribute to maximize their impact on busi...

It plans more work on end-to-end network solution models Its expansion needs funding – membership fees have been introduced New board member Ihab Tarazi says open networks are no longer an ‘experiment’  Encouraged by the traction that open, disaggregated network elements and architectures are now gaining with network operators, the Telecom Infra Project (TIP) is set to ramp up its efforts in 2021, with an even greater focus on end-to-end network solution models as well as individual netw...

Pharmaniaga will be the first biggest player in the race of developing its own Malaysian-made halal vaccines by 2024. WITH the vaccine rollout starting to take on more influence throughout the world and even here in Malaysia, it was no surprise that the pace of Malaysia’s own programme has started to flesh out in greater detail. That in turn has seen companies, which have long been entrenched in the healthcare theme, beginning to reveal more developments of their strategies. But more signific...

Despite signing a term sheet to supply 3.5 million doses of a Chinese Covid-19 to the Malaysian government, shares in Solution Group Bhd did not receive the expected boost today. Shares in the engineering and biopharmaceuticals company shed as much as 8.72% or 13 sen this morning. At 10.12am, shares in Solution Group were down 7.38% or 11 sen lower at RM1.38, translating into a market value of RM527.25 million.

“The term sheet agreement is to enable Solbio to enter into a definitive agreement to supply 3.5 million doses of the Recombinant Ad5-nCoV vaccine for the prevention of Covid-19. The vaccine is jointly developed by CanSino Biologics Inc and Beijing Institute of Biotechnology, Academy of Military Medical Sciences, ” the company said in a filing with Bursa Malaysia. ’s unit Solution Biologics Sdn Bhd (Solbio) said it has signed a term sheet agreement with the Health Ministry to supply Covid...

said wholly-owned subsidiary Solution Biologics Sdn Bhd (SolBio) has signed a term sheet agreement with the Ministry of Health (MoH) for the supply of Covid-19 vaccine. "The term sheet agreement, signed on Jan 29, is to enable SolBio to enter into a definitive supply agreement to supply 3.5 million doses of the Recombinant Ad5-nCoV vaccine," the company said in a filing today. The vaccine, Solution Group said, was jointly developed by CanSino Biologics Inc and Beijing Institute of Biotechnolog...

IF 2020 is the year of rubber glove manufacturers and technology-related counters, penny stocks deserve at least a notable mention. The penny stock fever on the local bourse has not been seen for at least 20 years since the dotcom bubble burst. The eye-popping share price rally lured long-absent retail investors to the stock market and that, in turn, lifted the daily trading volume to a record high of 27.8 billion shares on Aug 11. At the height of the penny stock fever in August, share prices ...